Supramolecular Coordination Complexes for Synergistic Cancer Therapy
Yang Li1, Feihe Huang2,3, Peter J Stang4
1Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, 311121 Hangzhou, P. R. China.
Platinum-based supramolecular coordination complexes (SCCs) offer enhanced cellular uptake and tumor accumulation for effective cancer therapy. These complexes enable synergistic multimodal treatments, combining chemotherapy with other modalities for improved antitumor efficacy and reduced toxicity.
Area of Science:
- Supramolecular chemistry
- Coordination chemistry
- Materials science
Background:
- Supramolecular coordination complexes (SCCs) are self-assemblies formed by metal ions and organic ligands.
- SCCs offer tunable architectures like metallacycles and metallacages with applications in biomedicine.
- Platinum-based SCCs show promise in cancer therapy due to enhanced cellular uptake and tumor targeting.
Purpose of the Study:
- To review recent research on platinum-based SCCs for synergistic cancer therapy.
- To highlight the cooperative interplay between different therapeutic methods within SCC platforms.
- To address the critical gap in understanding the synergistic multifunctionality of SCCs.
Main Methods:
- Focus on platinum-based SCCs and their application in cancer therapy.
- Summarize research on cooperative interplay between therapeutic methods.
- Discuss advantages of platinum-based SCCs: antitumor activity, low toxicity, tumor targeting, and enhanced cellular uptake.
Main Results:
- Platinum-based SCCs demonstrate potent antitumor activity and low systemic toxicity.
- These complexes exhibit enhanced cellular uptake and active tumor-targeting abilities.
- Integrated diagnostic and therapeutic modalities (chemotherapy, photothermal, photodynamic therapy) are achievable on a single SCC platform.
Conclusions:
- Platinum-based SCCs are promising candidates for synergistic cancer therapy.
- Their tunable structures and inherent properties facilitate multimodal treatment strategies.
- Future research should focus on further developing functional SCCs for integrated cancer treatment approaches.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11:14Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
